Search Results - Jan Gerstoft

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART by Helene Mens, Lasse Fjordside, Jannik Fonager, Jan Gerstoft

    Published in Infectious Disease Reports (2022-06-01)
    Get full text
    Article


  2. 2

    Thirty Years with HIV Infection—Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors by Julie C. Gaardbo, Hans J. Hartling, Jan Gerstoft, Susanne D. Nielsen

    Published in AIDS Research and Treatment (2012-01-01)
    Get full text
    Article


  3. 3

    Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions by Julie C. Gaardbo, Hans J. Hartling, Jan Gerstoft, Susanne D. Nielsen

    Published in Clinical and Developmental Immunology (2012-01-01)
    Get full text
    Article


  4. 4

    Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study. by Line D Rasmussen, Gitte Kronborg, Carsten S Larsen, Court Pedersen, Jan Gerstoft, Niels Obel

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  5. 5

    Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin by Marco Gelpi, Hans J. Hartling, Kristina Thorsteinsson, Jan Gerstoft, Henrik Ullum, Susanne D. Nielsen

    Published in BMC Infectious Diseases (2016-10-01)
    Get full text
    Article


  6. 6

    Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamivudine compared with continued treatment with dolutegravir/abacavir/lamivudine for vir... by Jan Gerstoft, Thomas Benfield, Søren Møller, Jens Dahlgaard Hove, Hartwig Roman Siebner, Andreas Knudsen, Karen Brorup Heje Pedersen

    Published in BMJ Open (2023-08-01)
    Get full text
    Article


  7. 7

    Cause-specific excess mortality in siblings of patients co-infected with HIV and hepatitis C virus. by Ann-Brit Eg Hansen, Nicolai Lohse, Jan Gerstoft, Gitte Kronborg, Alex Laursen, Court Pedersen, Henrik Toft Sørensen, Niels Obel

    Published in PLoS ONE (2007-01-01)
    Get full text
    Article


  8. 8

    Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency by Julie Høgh, Malene Hove-Skovsgaard, Marco Gelpi, Anne Marie Reimer Jensen, Jan Gerstoft, Thomas Benfield, Heidi Storgaard, Susanne Dam Nielsen

    Published in BMC Infectious Diseases (2022-05-01)
    Get full text
    Article


  9. 9

    HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART). by Sanne Skov Jensen, Anders Fomsgaard, Marie Borggren, Jeanette Linnea Tingstedt, Jan Gerstoft, Gitte Kronborg, Line Dahlerup Rasmussen, Court Pedersen, Ingrid Karlsson

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  10. 10

    Aortic aneurysms and markers of platelet activation, hemostasis, and endothelial disruption in people living with HIV by Sylvester Klöcker Grønbæk, Julie Høgh, Andreas Dehlbæk Knudsen, Michael Huy Cuong Pham, Per Ejlstrup Sigvardsen, Andreas Fuchs, Jørgen Tobias Kühl, Lars Køber, Lars Køber, Jan Gerstoft, Jan Gerstoft, Thomas Benfield, Sisse Rye Ostrowski, Sisse Rye Ostrowski, Klaus Fuglsang Kofoed, Klaus Fuglsang Kofoed, Klaus Fuglsang Kofoed, Susanne Dam Nielsen, Susanne Dam Nielsen

    Published in Frontiers in Immunology (2023-02-01)
    Get full text
    Article


  11. 11

    HIV and schistosomiasis in rural Zimbabwe: the association of Retinol-binding protein with disease progression, inflammation and mortality by Sebastian Ranzi Kotzé, Rutendo Zinyama-Gutsire, Per Kallestrup, Christine Stabell Benn, Exnevia Gomo, Jan Gerstoft, Govert van Dam, Ole Hartvig Mortensen, Henrik Ullum, Christian Erikstrup

    Get full text
    Article


  12. 12

    APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon. by Andrew E Armitage, Koen Deforche, Chih-Hao Chang, Edmund Wee, Beatrice Kramer, John J Welch, Jan Gerstoft, Lars Fugger, Andrew McMichael, Andrew Rambaut, Astrid K N Iversen

    Published in PLoS Genetics (2012-01-01)
    Get full text
    Article


  13. 13

    Cytomegalovirus Antibodies and Coronary Artery Disease in People with HIV: A Cohort Study by Moises Alberto Suarez-Zdunek, Andreas Dehlbæk Knudsen, Andreas Fuchs, Nikolai Søren Kirkby, Thomas Benfield, Jan Gerstoft, Marius Trøseid, Sisse Rye Ostrowski, Lars Valeur Køber, Klaus Fuglsang Kofoed, Susanne Dam Nielsen

    Published in Viruses (2025-02-01)
    Get full text
    Article


  14. 14

    Survival among people with HIV and their families in Denmark 1995–2021: a nationwide population-based cohort studyResearch in context by Caroline Eves, Lars Haukali Omland, Jan Gerstoft, Gitte Kronborg, Isik Somuncu Johansen, Carsten Schade Larsen, Anders Porskrog, Michael Dalager-Pedersen, Suzanne Lunding, Steffen Leth, Lars Nørregaard Nielsen, Malte Mose Tetens, Niels Obel

    Published in The Lancet Regional Health. Europe (2024-08-01)
    Get full text
    Article


  15. 15

    Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations. by Christina Sølund, Henrik Krarup, Santseharay Ramirez, Peter Thielsen, Birgit T Røge, Suzanne Lunding, Toke S Barfod, Lone G Madsen, Britta Tarp, Peer B Christensen, Jan Gerstoft, Alex L Laursen, Jens Bukh, Nina Weis, DANHEP group

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  16. 16

    Copenhagen comorbidity in HIV infection (COCOMO) study: a study protocol for a longitudinal, non-interventional assessment of non-AIDS comorbidity in HIV infection in Denmark by Andreas Ronit, Judith Haissman, Ditte Marie Kirkegaard-Klitbo, Thomas Skårup Kristensen, Anne-Mette Lebech, Thomas Benfield, Jan Gerstoft, Henrik Ullum, Lars Køber, Andreas Kjær, Klaus Kofoed, Jørgen Vestbo, Børge Nordestgaard, Jens Lundgren, Susanne Dam Nielsen

    Published in BMC Infectious Diseases (2016-11-01)
    Get full text
    Article


  17. 17

    HIV-1 Adaptation to Antigen Processing Results in Population-Level Immune Evasion and Affects Subtype Diversification by Stefan Tenzer, Hayley Crawford, Phillip Pymm, Robert Gifford, Vattipally B. Sreenu, Mirjana Weimershaus, Tulio de Oliveira, Anne Burgevin, Jan Gerstoft, Nadja Akkad, Daniel Lunn, Lars Fugger, John Bell, Hansjörg Schild, Peter van Endert, Astrid K.N. Iversen

    Published in Cell Reports (2014-04-01)
    Get full text
    Article


  18. 18

    No changes in weight, body composition or metabolic parameters after the switch to dolutegravir and lamivudine compared to continued treatment with dolutegravir, abacavir and lamiv... by Karen Brorup Heje, Magnus Søltoft Lindhardt, Alessandra Meddis, Andreas Knudsen, Gitte Kronborg, Nina Weis, Anne-Mette Lebech, Ole Kirk, Jannik Helweg-Larsen, Morten Helms, Christian Philip Fischer, Ann-Brit Eg Hansen, Søren Møller, Hartwig Roman Siebner, Jens Dahlgaard Hove, Jan Gerstoft, Thomas Benfield

    Published in BMC Infectious Diseases (2025-09-01)
    Get full text
    Article


  19. 19

    All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre... by Christian Kraef, Erich Tusch, Sabine Singh, Lars Østergaard, Gerd Fätkenheuer, Antonella Castagna, Santiago Moreno, Katharina Kusejko, Bartosz Szetela, Anastasiia Kuznetsova, Janez Tomažič, Jovan Ranin, Robert Zangerle, Fredrik Mansson, Giulia Marchetti, Stéphane De Wit, Amanda Clarke, Jan Gerstoft, Daria Podlekareva, Lars Peters, Joanne Reekie, Ole Kirk

    Published in The Lancet Regional Health. Europe (2024-09-01)
    Get full text
    Article


  20. 20

    Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort studyRes... by Line Dam Heftdal, Laura Pérez-Alós, Rasmus Bo Hasselbalch, Cecilie Bo Hansen, Sebastian Rask Hamm, Dina Leth Møller, Mia Pries-Heje, Kamille Fogh, Jan Gerstoft, Kirsten Grønbæk, Sisse Rye Ostrowski, Ruth Frikke-Schmidt, Erik Sørensen, Linda Hilsted, Henning Bundgaard, Peter Garred, Kasper Iversen, Caroline Sabin, Susanne Dam Nielsen

    Published in EBioMedicine (2023-07-01)
    Get full text
    Article


Search Tools: